{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ginkgo biloba", "bilberry", "glaucoma", "intraocular pressure", "marijuana", "medicinal plants", "visual field"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32607093", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "29"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1551-4056", "JournalIssue": {"Volume": "93", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Jun"}}, "Title": "The Yale journal of biology and medicine", "ISOAbbreviation": "Yale J Biol Med"}, "ArticleTitle": "Herbal Medicines in Glaucoma Treatment.", "Pagination": {"StartPage": "347", "EndPage": "353", "MedlinePgn": "347-353"}, "Abstract": {"AbstractText": ["Glaucoma is the leading cause of irreversible blindness worldwide. Optimizing treatment is important to protecting vision. The current standard of therapy for glaucoma involves lowering the intraocular pressure (IOP) through medical, laser, and/or surgical therapy. Nevertheless, there are an increasing number of glaucoma patients that use alternative medicines to treat their glaucoma or supplement their traditional glaucoma management. Ginkgo biloba, bilberry, and medical marijuana are amongst the most commonly used medicinal plants by glaucoma patients. We reviewed the literature to determine the benefits, safety, and efficacy of these herbal remedies. Though ginkgo biloba and bilberry may prevent or slow down retinal ganglion cell death, there is no evidence yet to suggest that they alter the course of glaucoma. Medical marijuana has shown IOP lowering effect in some individuals, but its short duration of action, significant adverse effects, and addictive potential have rendered it an inappropriate standard therapeutic agent for glaucoma. Larger studies with longer durations that investigate the effect of herbal medicines on the course of glaucoma in comparison to the current standard of care are needed to elucidate their benefits in glaucoma treatment."], "CopyrightInformation": "Copyright \u00a92020, Yale Journal of Biology and Medicine."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Yale University School of Medicine, New Haven, CT."}], "LastName": "Ige", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT."}], "LastName": "Liu", "ForeName": "Ji", "Initials": "J"}], "GrantList": [{"GrantID": "T35 AG049685", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "UL1 TR001863", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Yale J Biol Med", "NlmUniqueID": "0417414", "ISSNLinking": "0044-0086"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Glaucoma"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Intraocular Pressure"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Vaccinium myrtillus"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005. December;78(5):431\u201341. 10.1016/j.lfs.2005.09.012", "ArticleIdList": ["10.1016/j.lfs.2005.09.012", "16198377"]}, {"Citation": "Wyk B-Ev Wink M. Medicinal plants of the world an illustrated scientific guide to important medicina plants and theier uses. Timber Press Inc.; 2017."}, {"Citation": "Rhee DJ, Katz LJ, Spaeth GL, Myers JS. Complementary and alternative medicine for glaucoma. Surv Ophthalmol. 2001. Jul-Aug;46(1):43\u201355. 10.1016/s0039-6257(01)00233-8 10.1016/S0039-6257(01)00233-8", "ArticleIdList": ["10.1016/s0039-6257(01)00233-8", "10.1016/S0039-6257(01)00233-8", "11525790"]}, {"Citation": "Allingham RR, Damji KF, Shields MB. Shields textbook of glaucoma. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. pp. 433\u20137."}, {"Citation": "Yunard A, Oktariana VD, Artini W, Prihartono J. Comparison of Intraocular Pressure and Anterior Chamber Angle Changes between Pilocarpine and Laser Peripheral Iridotomy. J Curr Glaucoma Pract. 2019. Jan-Apr;13(1):32\u20136. 10.5005/jp-journals-10078-1245", "ArticleIdList": ["10.5005/jp-journals-10078-1245", "PMC6710935", "31496559"]}, {"Citation": "Wilkinson JT, Fraunfelder FW. Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review. Drugs. 2011. December;71(18):2421\u201334. 10.2165/11596840-000000000-00000", "ArticleIdList": ["10.2165/11596840-000000000-00000", "22141385"]}, {"Citation": "Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014. November;121(11):2081\u201390. 10.1016/j.ophtha.2014.05.013", "ArticleIdList": ["10.1016/j.ophtha.2014.05.013", "24974815"]}, {"Citation": "Prum BE, Jr, Lim MC, Mansberger SL, Stein JD, Moroi SE, Gedde SJ, et al. Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(\u00ae) Guidelines. Ophthalmology. 2016. January;123(1):112\u201351. 10.1016/j.ophtha.2015.10.055", "ArticleIdList": ["10.1016/j.ophtha.2015.10.055", "26581560"]}, {"Citation": "Binns CW, Lee MK, Lee AH. Problems and Prospects: Public Health Regulation of Dietary Supplements. Annu Rev Public Health. 2018. April;39(1):403\u201320. 10.1146/annurev-publhealth-040617-013638", "ArticleIdList": ["10.1146/annurev-publhealth-040617-013638", "29272167"]}, {"Citation": "Thomson P, Jones J, Browne M, Leslie SJ. Why people seek complementary and alternative medicine before conventional medical treatment: a population based study. Complement Ther Clin Pract. 2014. November;20(4):339\u201346. 10.1016/j.ctcp.2014.07.008", "ArticleIdList": ["10.1016/j.ctcp.2014.07.008", "25156988"]}, {"Citation": "Wan MJ, Daniel S, Kassam F, Mutti G, Butty Z, Kasner O, et al. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2012. February;21(2):79\u201382. 10.1097/IJG.0b013e3182027c0c", "ArticleIdList": ["10.1097/IJG.0b013e3182027c0c", "21173701"]}, {"Citation": "Rhee DJ, Spaeth GL, Myers JS, Steinmann WC, Augsburger JJ, Shatz LJ, et al. Prevalence of the use of complementary and alternative medicine for glaucoma. Ophthalmology. 2002. March;109(3):438\u201343. 10.1016/s0161-6420(01)01030-2 10.1016/S0161-6420(01)01030-2", "ArticleIdList": ["10.1016/s0161-6420(01)01030-2", "10.1016/S0161-6420(01)01030-2", "11874744"]}, {"Citation": "Belyea DA, Alhabshan R, Del Rio-Gonzalez AM, Chadha N, Lamba T, Golshani C, et al. Marijuana Use Among Patients With Glaucoma in a City With Legalized Medical Marijuana Use. JAMA Ophthalmol. 2016. March;134(3):259\u201364. 10.1001/jamaophthalmol.2015.5209", "ArticleIdList": ["10.1001/jamaophthalmol.2015.5209", "26719907"]}, {"Citation": "Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000. May;81(5):668\u201378. 10.1016/s0003-9993(00)90052-2 10.1016/S0003-9993(00)90052-2", "ArticleIdList": ["10.1016/s0003-9993(00)90052-2", "10.1016/S0003-9993(00)90052-2", "10807109"]}, {"Citation": "de Souza Silva JE, Santos Souza CA, da Silva TB, Gomes IA, Brito GC, de Souza Ara\u00fajo AA, et al. Use of herbal medicines by elderly patients: A systematic review. Arch Gerontol Geriatr. 2014. Sep-Oct;59(2):227\u201333. 10.1016/j.archger.2014.06.002", "ArticleIdList": ["10.1016/j.archger.2014.06.002", "25063588"]}, {"Citation": "Gauthier AC, Liu J. Neurodegeneration and Neuroprotection in Glaucoma. Yale J Biol Med. 2016. March;89(1):73\u20139.", "ArticleIdList": ["PMC4797839", "27505018"]}, {"Citation": "Goyal A, Srivastava A, Sihota R, Kaur J. Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients. Curr Eye Res. 2014. August;39(8):823\u20139. 10.3109/02713683.2011.556299", "ArticleIdList": ["10.3109/02713683.2011.556299", "24912005"]}, {"Citation": "Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol. 2004. January;137(1):62\u20139. 10.1016/s0002-9394(03)00788-8 10.1016/S0002-9394(03)00788-8", "ArticleIdList": ["10.1016/s0002-9394(03)00788-8", "10.1016/S0002-9394(03)00788-8", "14700645"]}, {"Citation": "Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008. January;14:224\u201333.", "ArticleIdList": ["PMC2267728", "18334938"]}, {"Citation": "Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006. December;26(49):12633\u201341. 10.1523/JNEUROSCI.2801-06.2006", "ArticleIdList": ["10.1523/JNEUROSCI.2801-06.2006", "PMC6674838", "17151265"]}, {"Citation": "Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC. Glia-neuron interactions in the mammalian retina. Prog Retin Eye Res. 2016. March;51:1\u201340. 10.1016/j.preteyeres.2015.06.003", "ArticleIdList": ["10.1016/j.preteyeres.2015.06.003", "26113209"]}, {"Citation": "Wang K, Peng B, Lin B. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model. Glia. 2014. December;62(12):1943\u201354. 10.1002/glia.22715", "ArticleIdList": ["10.1002/glia.22715", "24989686"]}, {"Citation": "Geyman LS, Suwan Y, Garg R, Field MG, Krawitz BD, Mo S, et al. Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma. J Glaucoma. 2018. July;27(7):592\u20139. 10.1097/ijg.0000000000000980 10.1097/IJG.0000000000000980", "ArticleIdList": ["10.1097/ijg.0000000000000980", "10.1097/IJG.0000000000000980", "29750714"]}, {"Citation": "Lascaratos G, Garway-Heath DF, Willoughby CE, Chau KY, Schapira AH. Mitochondrial dysfunction in glaucoma: understanding genetic influences. Mitochondrion. 2012. March;12(2):202\u201312. 10.1016/j.mito.2011.11.004", "ArticleIdList": ["10.1016/j.mito.2011.11.004", "22138560"]}, {"Citation": "Mirzaei M, Gupta VB, Chick JM, Greco TM, Wu Y, Chitranshi N, et al. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep. 2017. October;7(1):12685. 10.1038/s41598-017-12858-7", "ArticleIdList": ["10.1038/s41598-017-12858-7", "PMC5627288", "28978942"]}, {"Citation": "Eckert A, Keil U, Scherping I, Hauptmann S, M\u00fcller WE. Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann N Y Acad Sci. 2005. November;1056(1):474\u201385. 10.1196/annals.1352.023", "ArticleIdList": ["10.1196/annals.1352.023", "16387710"]}, {"Citation": "Wu Y, Li S, Cui W, Zu X, Du J, Wang F. Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation. Phytomedicine. 2008. March;15(3):164\u20139. 10.1016/j.phymed.2007.12.002", "ArticleIdList": ["10.1016/j.phymed.2007.12.002", "18258419"]}, {"Citation": "Huang SY, Jeng C, Kao SC, Yu JJ, Liu DZ. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr. 2004. August;23(4):615\u201321. 10.1016/j.clnu.2003.10.010", "ArticleIdList": ["10.1016/j.clnu.2003.10.010", "15297098"]}, {"Citation": "Cybulska-Heinrich AK, Mozaffarieh M, Flammer J. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Mol Vis. 2012;18:390\u2013402.", "ArticleIdList": ["PMC3283204", "22355250"]}, {"Citation": "Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003. February;110(2):359\u201362. 10.1016/S0161-6420(02)01745-1", "ArticleIdList": ["10.1016/S0161-6420(02)01745-1", "12578781"]}, {"Citation": "Guo X, Kong X, Huang R, Jin L, Ding X, He M, et al. Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Vis Sci. 2014. January;55(1):110\u20136. 10.1167/iovs.13-13168", "ArticleIdList": ["10.1167/iovs.13-13168", "24282229"]}, {"Citation": "Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma. Korean J Ophthalmol. 2011. October;25(5):323\u20138. 10.3341/kjo.2011.25.5.323", "ArticleIdList": ["10.3341/kjo.2011.25.5.323", "PMC3178766", "21976939"]}, {"Citation": "Sari MD, Sihotang AD, Lelo A. Ginkgo biloba extract effect on oxidative stress marker malonildialdehyde, redox enzyme gluthation peroxidase, visual field damage, and retinal nerve fiber layer thickness in primary open angle glaucoma. Int J Pharm Tech Res. 2016;9:158\u201366."}, {"Citation": "DeKosky ST, Fitzpatrick A, Ives DG, Saxton J, Williamson J, Lopez OL, et al. GEMS Investigators The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials. 2006. June;27(3):238\u201353. 10.1016/j.cct.2006.02.007", "ArticleIdList": ["10.1016/j.cct.2006.02.007", "16627007"]}, {"Citation": "DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, et al. Ginkgo Evaluation of Memory (GEM) Study Investigators Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008. November;300(19):2253\u201362. 10.1001/jama.2008.683", "ArticleIdList": ["10.1001/jama.2008.683", "PMC2823569", "19017911"]}, {"Citation": "Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology. 2008. May;70(19 Pt 2):1809\u201317. 10.1212/01.wnl.0000303814.13509.db", "ArticleIdList": ["10.1212/01.wnl.0000303814.13509.db", "PMC2639649", "18305231"]}, {"Citation": "West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006. January;141(1):157\u201366. 10.1016/j.ajo.2005.07.033", "ArticleIdList": ["10.1016/j.ajo.2005.07.033", "16386992"]}, {"Citation": "G\u00e1bor M. Pharmacologic effects of flavonoids on blood vessels. Angiologica. 1972;9(3-6):355\u201374. 10.1159/000157944", "ArticleIdList": ["10.1159/000157944", "4592457"]}, {"Citation": "Head KA. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev. 2001. April;6(2):141\u201366.", "ArticleIdList": ["11302779"]}, {"Citation": "Mian E, Curri SB, Lietti A, Bombardelli E. [Anthocyanosides and the walls of the microvessels: further aspects of the mechanism of action of their protective effect in syndromes due to abnormal capillary fragility]. Minerva Med. 1977. October;68(52):3565\u201381.", "ArticleIdList": ["593582"]}, {"Citation": "Shim SH, Kim JM, Choi CY, Kim CY, Park KH. Ginkgo biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J Med Food. 2012. September;15(9):818\u201323. 10.1089/jmf.2012.2241", "ArticleIdList": ["10.1089/jmf.2012.2241", "PMC3429325", "22870951"]}, {"Citation": "Ohguro H, Ohguro I, Katai M, Tanaka S. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma. Ophthalmologica. 2012;228(1):26\u201335. 10.1159/000335961", "ArticleIdList": ["10.1159/000335961", "22377796"]}, {"Citation": "Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America. Eur J Intern Med. 2018. March;49:2\u20136. 10.1016/j.ejim.2018.01.001", "ArticleIdList": ["10.1016/j.ejim.2018.01.001", "29329891"]}, {"Citation": "National Conference of State Legislatures  State Medical Marijuana Laws [Internet]. 2019.  Available from: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx"}, {"Citation": "Zhan GL, Camras CB, Palmberg PF, Toris CB. Effects of marijuana on aqueous humor dynamics in a glaucoma patient. J Glaucoma. 2005. April;14(2):175\u20137. 10.1097/01.ijg.0000151882.07232.1d", "ArticleIdList": ["10.1097/01.ijg.0000151882.07232.1d", "15741823"]}, {"Citation": "Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012. December;2(6):241\u201354. 10.1177/2045125312457586", "ArticleIdList": ["10.1177/2045125312457586", "PMC3736954", "23983983"]}, {"Citation": "Katz J, Costarides AP. Facts vs Fiction: the Role of Cannabinoids in the Treatment of Glaucoma. Curr Ophthalmol Rep. 2019;7(3):177\u201381. 10.1007/s40135-019-00214-z", "ArticleIdList": ["10.1007/s40135-019-00214-z"]}, {"Citation": "Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA. 1971. September;217(10):1392. 10.1001/jama.1971.03190100074024", "ArticleIdList": ["10.1001/jama.1971.03190100074024", "5109652"]}, {"Citation": "Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998. November;116(11):1433\u20137. 10.1001/archopht.116.11.1433", "ArticleIdList": ["10.1001/archopht.116.11.1433", "9823341"]}, {"Citation": "Sun X, Xu CS, Chadha N, Chen A, Liu J. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? Yale J Biol Med. 2015. September;88(3):265\u20139.", "ArticleIdList": ["PMC4553646", "26339209"]}, {"Citation": "Jay WM, Green K. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes. Arch Ophthalmol. 1983. April;101(4):591\u20133. 10.1001/archopht.1983.01040010591012", "ArticleIdList": ["10.1001/archopht.1983.01040010591012", "6301412"]}, {"Citation": "Porcella A, Maxia C, Gessa GL, Pani L. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur J Neurosci. 2001. January;13(2):409\u201312. 10.1046/j.0953-816x.2000.01401.x 10.1046/j.0953-816X.2000.01401.x", "ArticleIdList": ["10.1046/j.0953-816x.2000.01401.x", "10.1046/j.0953-816X.2000.01401.x", "11168547"]}, {"Citation": "Tiedeman JS, Shields MB, Weber PA, Crow JW, Cocchetto DM, Harris WA, et al. Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology. 1981. March;88(3):270\u20137. 10.1016/s0161-6420(81)35052-0 10.1016/S0161-6420(81)35052-0", "ArticleIdList": ["10.1016/s0161-6420(81)35052-0", "10.1016/S0161-6420(81)35052-0", "7015221"]}, {"Citation": "Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. \u03949-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Invest Ophthalmol Vis Sci. 2018. December;59(15):5904\u201311. 10.1167/iovs.18-24838", "ArticleIdList": ["10.1167/iovs.18-24838", "PMC6295937", "30550613"]}, {"Citation": "Tomida I, Azuara-Blanco A, House H, Flint M, Pertwee RG, Robson PJ. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. J Glaucoma. 2006. October;15(5):349\u201353. 10.1097/01.ijg.0000212260.04488.60", "ArticleIdList": ["10.1097/01.ijg.0000212260.04488.60", "16988594"]}, {"Citation": "Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. Br J Ophthalmol. 2004. May;88(5):708\u201313. 10.1136/bjo.2003.032250", "ArticleIdList": ["10.1136/bjo.2003.032250", "PMC1772142", "15090428"]}, {"Citation": "Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980. March;87(3):222\u20138. 10.1016/s0161-6420(80)35258-5 10.1016/S0161-6420(80)35258-5", "ArticleIdList": ["10.1016/s0161-6420(80)35258-5", "10.1016/S0161-6420(80)35258-5", "7053160"]}, {"Citation": "Novack GD. Cannabinoids for treatment of glaucoma. Curr Opin Ophthalmol. 2016. March;27(2):146\u201350. 10.1097/ICU.0000000000000242", "ArticleIdList": ["10.1097/ICU.0000000000000242", "26840343"]}, {"Citation": "Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009. March;360(11):1113\u201324. 10.1056/NEJMra0804630", "ArticleIdList": ["10.1056/NEJMra0804630", "PMC3700399", "19279343"]}, {"Citation": "Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol. 2008. March;19(2):85\u20138. 10.1097/ICU.0b013e3282f3919b", "ArticleIdList": ["10.1097/ICU.0b013e3282f3919b", "18301279"]}, {"Citation": "Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014. May;311(18):1901\u201311. 10.1001/jama.2014.3192", "ArticleIdList": ["10.1001/jama.2014.3192", "PMC4523637", "24825645"]}, {"Citation": "Lu LJ, Tsai JC, Liu J. Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma. Yale J Biol Med. 2017. March;90(1):111\u20138.", "ArticleIdList": ["PMC5369028", "28356898"]}, {"Citation": "Allingham RR, Damji KF, Shields MB. Shields textbook of glaucoma. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. pp. 390\u20139."}, {"Citation": "National Collaborating Centre for Acute Care (UK)  Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension [Internet]. London: National Collaborating Centre for Acute Care (UK); 2009.  Available from: http://www.ncbi.nlm.nih.gov/books/NBK61894/", "ArticleIdList": ["21938863"]}, {"Citation": "Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005;18(3):383-95, vi. Epub 2005/08/02. doi: 10.1016/j.ohc.2005.04.002. PubMed PMID: 16054996.", "ArticleIdList": ["10.1016/j.ohc.2005.04.002", "16054996"]}, {"Citation": "Sena DF, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2017. January;1:CD006539. 10.1002/14651858.CD006539.pub4", "ArticleIdList": ["10.1002/14651858.CD006539.pub4", "PMC5370094", "28122126"]}, {"Citation": "Loskutova E, O\u2019Brien C, Loskutov I, Loughman J. Nutritional supplementation in the treatment of glaucoma: A systematic review. Surv Ophthalmol. 2019. Mar-Apr;64(2):195\u2013216. 10.1016/j.survophthal.2018.09.005", "ArticleIdList": ["10.1016/j.survophthal.2018.09.005", "30296451"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["32607093", "PMC7309662", "yjbm932347"]}}], "PubmedBookArticle": []}